De Burlo Group Inc Edwards Lifesciences Corp Transaction History

De Burlo Group Inc

$808 Million
Q3 2024

A detailed history of De Burlo Group Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, De Burlo Group Inc holds 18,800 shares of EW stock, worth $1.27 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

18,800

Previous 18,900 0.53%

Holding current value

$1.27 Million

Previous $1.75 Million 28.94%

% of portfolio

0.15%

Previous 0.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$59.7 - $93.78 $5,970 - $9,378	-100 Reduced 0.53%	18,800 $1.24 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $4,215 - $4,715	-50 Reduced 0.26%	18,900 $1.75 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $61,659 - $81,226	-850 Reduced 4.29%	18,950 $1.81 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.45 Million - $1.89 Million	17,600 Added 800.0%	19,800 $1.64 Million
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $1.54 Million - $2.28 Million	-17,750 Reduced 88.97%	2,200 $209,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $8.23 Million - $10.4 Million	-80,700 Reduced 80.18%	19,950 $2.35 Million
Q4 2021 Jan 28, 2022	BUY	$106.37 - $130.68 $1.1 Million - $1.35 Million	10,300 Added 11.4%	100,650 $13 Million
Q3 2021 Nov 09, 2021	BUY	$102.91 - $122.75 $6.91 Million - $8.24 Million	67,100 Added 288.6%	90,350 $10.2 Million
Q1 2021 May 06, 2021	SELL	$78.68 - $90.67 $27,538 - $31,734	-350 Reduced 1.48%	23,250 $1.95 Million
Q4 2020 Feb 05, 2021	SELL	$71.69 - $91.23 $71,690 - $91,230	-1,000 Reduced 4.07%	23,600 $2.15 Million
Q3 2020 Nov 05, 2020	SELL	$67.19 - $87.44 $423,297 - $550,872	-6,300 Reduced 20.39%	24,600 $1.96 Million
Q1 2020 May 07, 2020	SELL	$52.41 - $81.0 $2.96 Million - $4.57 Million	-56,400 Reduced 64.6%	30,900 $5.83 Million
Q4 2019 Feb 06, 2020	SELL	$71.7 - $82.09 $417,652 - $478,174	-5,825 Reduced 6.26%	87,300 $20.4 Million
Q3 2019 Nov 07, 2019	BUY	$61.55 - $75.43 $3.04 Million - $3.73 Million	49,425 Added 113.1%	93,125 $20.5 Million
Q2 2019 Aug 07, 2019	SELL	$55.74 - $64.41 $1.74 Million - $2.01 Million	-31,250 Reduced 41.69%	43,700 $8.07 Million
Q1 2019 May 09, 2019	BUY	$47.89 - $64.05 $2.72 Million - $3.63 Million	56,750 Added 311.81%	74,950 $14.3 Million
Q4 2018 Feb 07, 2019	SELL	$46.41 - $56.94 $13,922 - $17,082	-300 Reduced 1.62%	18,200 $2.79 Million
Q3 2018 Nov 08, 2018	SELL	$45.7 - $58.03 $1.74 Million - $2.21 Million	-38,000 Reduced 67.26%	18,500 $3.22 Million
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $284,415 - $343,710	6,700 Added 13.45%	56,500 $8.22 Million
Q1 2018 May 03, 2018	BUY	$37.19 - $47.45 $1.15 Million - $1.47 Million	30,900 Added 163.49%	49,800 $6.95 Million
Q3 2017 Nov 02, 2017	BUY	$36.29 - $38.83 $685,881 - $733,887	18,900	18,900 $2.07 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on De Burlo Group Inc with notifications on news.

Account

De Burlo Group Inc Edwards Lifesciences Corp Transaction History